A kinase inhibitor screen identifies a dual cdc7/CDK9 inhibitor to sensitise triple-negative breast cancer to EGFR-targeted therapy

RP McLaughlin, JC He, VE van der Noord, J Redel, John Foekens, John Martens, Marcel Smid, YH Zhang, B van de Water

Research output: Contribution to journalArticleAcademicpeer-review

38 Citations (Scopus)
3 Downloads (Pure)
Original languageUndefined/Unknown
Article number77
JournalBreast Cancer Research
Publication statusPublished - 2019

Cite this